Burke & Herbert Bank & Trust Co. Raises Holdings in Cameco Corporation (NYSE:CCJ)

Burke & Herbert Bank & Trust Co. increased its position in shares of Cameco Corporation (NYSE:CCJ - Free Report) TSE: CCO by 203.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,750 shares of the basic materials company's stock after buying an additional 8,550 shares during the period. Burke & Herbert Bank & Trust Co.'s holdings in Cameco were worth $525,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Hurley Capital LLC purchased a new position in Cameco in the fourth quarter valued at about $27,000. Bank Julius Baer & Co. Ltd Zurich purchased a new position in Cameco in the fourth quarter valued at about $28,000. Copia Wealth Management purchased a new position in Cameco in the fourth quarter valued at about $39,000. Ameriflex Group Inc. purchased a new position in Cameco in the fourth quarter valued at about $40,000. Finally, Larson Financial Group LLC grew its stake in Cameco by 37.4% in the fourth quarter. Larson Financial Group LLC now owns 830 shares of the basic materials company's stock valued at $43,000 after purchasing an additional 226 shares during the last quarter. Hedge funds and other institutional investors own 70.21% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on CCJ shares. Stifel Nicolaus started coverage on Cameco in a report on Wednesday, March 12th. They issued a "buy" rating for the company. The Goldman Sachs Group raised their price target on Cameco from $65.00 to $78.00 and gave the stock a "buy" rating in a report on Wednesday, June 11th. Royal Bank Of Canada raised their price target on Cameco from $90.00 to $100.00 and gave the stock an "outperform" rating in a report on Friday, June 20th. Stifel Canada raised Cameco to a "strong-buy" rating in a report on Wednesday, March 12th. Finally, Glj Research reissued a "buy" rating and issued a $75.27 price target on shares of Cameco in a report on Thursday, June 12th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $80.65.

Cameco Stock Performance

Shares of Cameco stock traded down $3.26 on Tuesday, reaching $71.93. 6,406,661 shares of the stock were exchanged, compared to its average volume of 4,838,445. The company has a quick ratio of 1.26, a current ratio of 2.70 and a debt-to-equity ratio of 0.15. Cameco Corporation has a twelve month low of $35.00 and a twelve month high of $75.42. The firm has a market capitalization of $31.31 billion, a price-to-earnings ratio of 179.83 and a beta of 1.03. The business has a 50 day moving average price of $60.51 and a two-hundred day moving average price of $51.13.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last announced its quarterly earnings results on Thursday, May 1st. The basic materials company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.07). The company had revenue of $549.58 million during the quarter, compared to analyst estimates of $890.07 million. Cameco had a net margin of 7.50% and a return on equity of 4.47%. The company's revenue was up 24.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.13 earnings per share. Analysts anticipate that Cameco Corporation will post 1.27 earnings per share for the current fiscal year.

Cameco Company Profile

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.